CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Additional Paid-in Capital	Accumulated Deficit	Common Stock Class A Common Stock	Common Stock Class B Common Stock
Balance at Dec. 31, 2021	$ 186,227	$ 322,540	$ (136,320)	$ 5	$ 2
Balance (in shares) at Dec. 31, 2021				55,277,061	15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(23,775)		(23,775)
Stock-based compensation expense	4,111	4,111
Balance at Mar. 31, 2022	166,563	326,651	(160,095)	$ 5	$ 2
Balance (in shares) at Mar. 31, 2022				55,277,061	15,055,288
Balance at Dec. 31, 2021	186,227	322,540	(136,320)	$ 5	$ 2
Balance (in shares) at Dec. 31, 2021				55,277,061	15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(60,105)
Balance at Sep. 30, 2022	134,983	331,401	(196,425)	$ 5	$ 2
Balance (in shares) at Sep. 30, 2022				55,515,532	15,055,288
Balance at Mar. 31, 2022	166,563	326,651	(160,095)	$ 5	$ 2
Balance (in shares) at Mar. 31, 2022				55,277,061	15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(23,159)		(23,159)
Issuance of restricted stock				19,220
Exercise of stock options	2	2
Exercise of stock options (in shares)				16,375
Stock-based compensation expense	7,102	7,102
Balance at Jun. 30, 2022	150,508	333,755	(183,254)	$ 5	$ 2
Balance (in shares) at Jun. 30, 2022				55,312,656	15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(13,171)		(13,171)
Issuance of restricted stock				202,876
Stock-based compensation expense	(2,354)	(2,354)
Balance at Sep. 30, 2022	134,983	331,401	(196,425)	$ 5	$ 2
Balance (in shares) at Sep. 30, 2022				55,515,532	15,055,288
Balance at Dec. 31, 2022	123,722	333,199	(209,484)	$ 5	$ 2
Balance (in shares) at Dec. 31, 2022				55,622,488	15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(12,160)		(12,160)
Issuance of restricted stock				324,296
Exercise of stock options	49	49
Exercise of stock options (in shares)				54,211
Stock-based compensation expense	1,126	1,126
Balance at Mar. 31, 2023	112,737	334,374	(221,644)	$ 5	$ 2
Balance (in shares) at Mar. 31, 2023				56,000,995	15,055,288
Balance at Dec. 31, 2022	123,722	333,199	(209,484)	$ 5	$ 2
Balance (in shares) at Dec. 31, 2022				55,622,488	15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (33,554)
Exercise of stock options (in shares)	160,787
Balance at Sep. 30, 2023	$ 93,767	336,798	(243,038)	$ 5	$ 2
Balance (in shares) at Sep. 30, 2023				56,537,946	15,055,288
Balance at Mar. 31, 2023	112,737	334,374	(221,644)	$ 5	$ 2
Balance (in shares) at Mar. 31, 2023				56,000,995	15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(10,637)		(10,637)
Issuance of restricted stock				219,887
Exercise of stock options	58	58
Exercise of stock options (in shares)				63,656
Stock-based compensation expense	1,133	1,133
Balance at Jun. 30, 2023	103,291	335,565	(232,281)	$ 5	$ 2
Balance (in shares) at Jun. 30, 2023				56,284,538	15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(10,757)		(10,757)
Issuance of restricted stock				210,488
Exercise of stock options	39	39
Exercise of stock options (in shares)				42,920
Stock-based compensation expense	1,194	1,194
Balance at Sep. 30, 2023	$ 93,767	$ 336,798	$ (243,038)	$ 5	$ 2
Balance (in shares) at Sep. 30, 2023				56,537,946	15,055,288